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D URING THE CORONAVIRUS disease 2019 (COVID-19) pandemic, organizations have promoted concepts 
such as “We are in this together” to ensure 
buy-in and build communication with 
employees and the public.  
However, we should consider post-
pandemic times. We do not always 
have a crisis to solve or a critical body 
of evidence to point to when we need 
to change a work process, influence 
employees to support changes, improve 
products, or increase medication safety. As 
leaders, we should always ask ourselves: Is 
change necessary? How do we effectively 
implement the change? How do we articu-
late the benefits of the change? How do we 
sustain efforts after the change?
Change management (CM) is a 
well-organized framework for managing 
the people side of change.1 It includes 
practices, processes, and planned activities 
designed to facilitate and lead 
organizations to move from the present 
state to a desired state.2 The goal of CM is 
not to eliminate resistance but to anticipate 
it, proactively plan for it, continuously 
manage it, and mitigate the consequences.3
In some settings, such as hospitals, 
there are important challenges to changing 
processes. Clinicians have high individual 
autonomy and show various degrees of 
professional dominance over management 
and patients, which gives them control 
and power.4,5 CM practices are often only 
considered retrospectively in practice 
after challenges or implementation 
difficulty occur.6 
Step 1: Identifying What Needs to 
Be Changed
The first step in most CM models is identi-
fying what needs to be changed. A good way 
to examine this in health care is the Swiss 
cheese model related to patient safety.7 
Perhaps the task or item is not meeting 
expectations or there is a need to increase 
effectiveness, operational efficiency, patient 
safety, or productivity. In either event, 
the element that needs to be changed is 
identified. Then we recognize what exactly 
should change, who will be affected, and 
who the stakeholders are. Leadership must 
realize that change may not be positive 
for all stakeholders and may be perceived 
as negative by some.
An example is rationing products for 
personal protective equipment (PPE) 
during supply chain disruptions from the 
pandemic. Another is increasing telephar-
macy use to provide care and education 
to patients while protecting clinicians 
and patients from unnecessary exposure 
to COVID-19 and advancing medication 
management and safety. In these cases, 
what needed to change was apparent to 
those involved. If a patient could not come 
to the clinic to get care or equipment was 
not available, an alternative was required.
Step 2: Determining the New Way of 
Doing Business
Once a needed change is identified, a new 
process should be identified. One case 
in pharmacy practice is using alternative 
compounded products instead of commer-
cially available products to address supply 
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chain shortages caused by stressors during 
the pandemic. A matrix can be developed to 
aid in this process, such as the Six Thinking 
Hats, in which various points of view are 
considered to evaluate the best ideas.8 This 
type of thinking can help determine the best 
choice and provide feedback to stakeholders 
about why the option(s) being proposed are 
better. This will allow the proposed change 
to build critical mass to support the change.
Step 3: Implement and Maintain
To implement and sustain change, it must 
address who is going to do what and when. 
An example would be inventory-control 
functions for the COVID-19 vaccine 
supply. Everyone involved with the supply 
chain and planning needs to understand 
their role. The COVID-19 vaccine supply 
chain includes managing cold storage, 
thawing, and complex administration and 
scheduling processes.
Once a plan is in place, stakeholders 
need to be informed that the change is 
starting. Once implemented, it should be 
determined if the results were obtained. 
Depending on the change, a new policy 
may be written and employees trained 
accordingly to sustain the change. Step 3 is 
the point in which CM can fail and cause 
a new process to increase the number of 
errors in the short term, if the new standard 
work is not written clearly. Finally, there is 
a need to codify the change so the process 
does not backslide over time.
Conclusion
The pandemic has caused leadership to 
implement change more rapidly than usual 
and rethink how business and process 
operates, including managing the supply 
chain, deploying staff, ensuring medication 
safety, and using personal protective equip-
ment. Additionally, to effectively manage 
identified change, CM should encompass 
a standardized procedure. Although CM 
can be a daunting process, a thoughtful 
application will reduce the resistance to 
change and improve overall operations, 
regardless of where it is applied if it 
follows consistent steps. ■
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